DALT

N,N-Diallyltryptamine (DALT) is a tryptamine derivative which has been identified as a new psychoactive substance.^[2][3] It has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.^[4]

DALT

Clinical data
Other names	N,N-Diallyltryptamine; DALT; DAT
Routes of administration	Oral, intramuscular injection[1]
Drug class	Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code	None
Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class A US: Analogue to a Schedule I/II drug (possibly) UN: Unscheduled but not approved for human consumption. in theory could be covered under similar analogue bills in other countries but this is not confirmed.
Identifiers
IUPAC name N-Allyl-N-[2-(1H-indol-3-yl)ethyl]prop-2-en-1-amine
CAS Number	60676-77-9
PubChem CID	24839550
ChemSpider	21250454 Y
UNII	85113MO9BC
CompTox Dashboard (EPA)	DTXSID001024249
Chemical and physical data
Formula	C16H20N2
Molar mass	240.350 g·mol−1
3D model (JSmol)	Interactive image
SMILES C=CCN(CC=C)CCc2c[nH]c1ccccc12
InChI InChI=1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 Y Key:LQEATNFJCMVKAC-UHFFFAOYSA-N Y
(verify)

Use and effects

According to Alexander Shulgin in TiHKAL, the dosage of DALT is >40 mg orally and its duration is unknown.^[1] Its effects have not been described.^[1] According to Stephen Szara and colleagues however, DALT and other extended N,N-dialkyltryptamines produce similar effects to dimethyltryptamine (DMT) but are longer-lasting, with durations of up to 3 hours.^[1][5][6]

Pharmacology

DALT activities

Target	Affinity (Ki, nM)
5-HT1A	100
5-HT1B	>10,000
5-HT1D	689
5-HT1E	378
5-HT1F	ND
5-HT2A	701
5-HT2B	61
5-HT2C	385
5-HT3	>10,000
5-HT4	ND
5-HT5A	>10,000
5-HT6	1,718
5-HT7	>10,000
α1A	1,663
α1B	1,369
α1D	>10,000
α2A	124
α2B	305
α2C	901
β1–β3	>10,000
D1, D2	>10,000
D3	672
D4, D5	>10,000
H1	127
H2–H4	>10,000
M1–M5	>10,000
I1	ND
σ1	101 (rat)
σ2	356 (rat)
TAAR1Tooltip Trace amine-associated receptor 1	ND
MORTooltip μ-Opioid receptor, DORTooltip δ-Opioid receptor	>10,000
KORTooltip κ-Opioid receptor	2,477
SERTTooltip Serotonin transporter	150 (Ki)
NETTooltip Norepinephrine transporter	1,121 (Ki)
DATTooltip Dopamine transporter	1,406 (Ki)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs: [7][8][9][10]

The receptor interactions of DALT have been studied.^{[7][8][9][10]} The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.^[11]

History

DALT was first described in the scientific literature by Stephen Szara and colleagues by 1962.^[5][6]

See also

• Substituted tryptamine
• 4-HO-DALT
• 4-AcO-DALT
• 5-MeO-DALT